<img src="https://secure.leadforensics.com/125032.png" alt="" style="display:none;">
Back to Investments
chase-colour

Pharmaceutical CSO

Vespa Capital acquired Chase in 2016

Business Profile

  • Chase is a bespoke contract sales organisation (CSO) and provider of specialist recruitment services to blue chip pharmaceutical, biotech and healthcare companies in the UK. It’s the clear quality leader in the UK market.

  • The Chase network efficiently and rapidly sources the highest quality, most suitable personnel for their clients bespoke requirements. Chase’s operations deliver a market leading on-boarding experience and ongoing pastoral care to their selected contractors.

  • Across its three divisions, Chase has strong and established relationships with the top 20 pharmaceutical companies, which have ongoing sales and marketing executive recruitment and CSO requirements, in addition to numerous national clinical studies.

Key Strengths

Vespa Capital invested in Chase Search & Selection in July 2016 attracted by its international blue chip customer base, its strong reputation within its industry and the strength of its customer relationships. Since acquiring the business, Vespa Capital has supported the management team to develop new service lines and helped put in place a succession plan.

  • Strong management team; two founding Directors with over 17 years’ experience, working alongside impressive operators with significant experience within the business’ chosen markets.
  • Unique synergistic business model and candidate intelligence allows the business to source high quality personnel quicker than the competition.
  • Named the leading recruiter in the pharmaceutical sector for the past eight years and was named CSO of the year in 2015 and again in 2017.
  • High levels of customer satisfaction and repeat business, driven by the high level of service, ethics and integrity demonstrated by both the operational staff at Chase and the 250+ contract sales personnel currently deployed.
  • Strong growth opportunities in managed and unmanaged CSO provision, to both existing customers and in the development of adjacent markets.

What Chase says

Vespa Capital is a business which holds similar beliefs, business practices and ethics to Chase. The investment by Vespa Capital has enabled Chase to incentivise key personnel moving forward and will allow us to accelerate our growth by investing in adjacent products and services. Additionally, Chase will maintain its current quality offering which differentiates us from other CSOs.

Chris Phillips, CEO, Chase Search and Selection